The biology of steroid hormones and endocrine treatment of breast cancer

Breast

Volumn 14, Issue 6, 2005, Pages 452-457

  Dowsett, Mitch ^a   Folkerd, Elizabeth ^a   Doody, Deborah ^a   Haynes, Ben ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Aromatase; Breast cancer; Oestrogen

Indexed keywords

4 [N (4 BROMOBENZYL) N (1,2,4 TRIAZOL 4 YL)AMINO]BENZONITRILE; ANASTROZOLE; ANDROGEN; ANDROSTENEDIONE; AROMATASE INHIBITOR; ESTRADIOL; ESTROGEN; FOLLITROPIN; FORMESTANE; GONADORELIN AGONIST; GOSERELIN; LETROZOLE; LUTEINIZING HORMONE; PLACEBO; SEX HORMONE BINDING GLOBULIN; STEROID HORMONE; TAMOXIFEN; TESTOSTERONE; VOROZOLE;

ACCURACY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER HORMONE THERAPY; CANCER RISK; CLINICAL TRIAL; CYSTIC FIBROSIS; DRUG DOSE REGIMEN; ENDOMETRIOSIS; ENZYME INHIBITION; ESTRADIOL BLOOD LEVEL; ESTROGEN SYNTHESIS; HIGH RISK PATIENT; HORMONE BLOOD LEVEL; HUMAN; OVARIECTOMY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; TUMOR GROWTH;

EID: 28044459820     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2005.08.019     Document Type: Article

References (16)

1. P.K. Siiteri P.C. MacDonald Role of extraglandular estrogen in human endocrinology In: S.R. Geiger et al. editors. Handbook of physiology 1973 Williams & Wilkins Baltimore 615-629
2. J. Geisler B. Haynes G. Anker M. Dowsett P.E. Lonning Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study J Clin Oncol 20 2002 751-757
3. A.M. Dunning M. Dowsett C.S. Healey et al. Polymorphisms associated with circulating sex hormone levels in postmenopausal women J Natl Cancer Inst 96 2004 936-945
4. T.J. Key D. Phil ICRF Cancer Epidemiology Unit, University of Oxford, and affiliations of the Endogenous Hormones and Breast Cancer Collaborative Group Endogenous sex hormones and breast cancer in postmenopausal women: Reanalysis of nine prospective studies J Natl Cancer Inst 94 2002 606-616
5. T.J. Key P.N. Appleby G.K. Reeves of the Endogenous Hormones Breast Cancer Collaborative Group et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women J Natl Cancer Inst 95 2003 1218-1226
6. M. Dowsett Clinical trials with aromatase inhibitors for the prevention of breast cancer In: J.N. Ingle M. Dowsett editors. Advances in endocrine therapy of breast cancer 2004 Dekker New York 189-201
7. M. Dowsett R.C. Stein R.C. Coombes Aromatization inhibition alone or in combination with GnRH agonists for the treatment of premenopausal breast cancer patients J Steroid Biochem 43 1992 155-159
8. K.G. Klijn L.V. Beex L. Mauriac et al. Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: A randomized study J Natl Cancer Inst 92 2000 903-911
9. M. Dowsett B.P. Haynes Hormonal effects of aromatase inhibitors: Focus on premenopausal effects and interaction with tamoxifen J Steroid Biochem Mol Biol 86 2003 255-263
10. R.C. Stein M. Dowsett A. Hedley R.C. Coombes The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancer Br J Cancer 62 1990 679-683
11. M. Dowsett D. Doody S. Miall A. Howes J. English R.C. Coombes Vorozole results in greater oestrogen suppression than formestane in postmenopausal women and when added to goserelin in premenopausal women with advanced breast cancer Br Cancer Res Treat 56 1999 25-34
12. P.E. Lonning D.C. Johannessen E.A. Lien D. Ekse T. Fotsis H. Adlercreutz Influence of tamoxifen on sex hormones, gonadotrophins and sex hormone binding globulin in postmenopausal breast cancer patients J Steroid Biochem Mol Biol 52 1995 491-496
13. J. Geisler N. King G. Anker et al. In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients Clin Cancer Res 4 1998 2089-2093
14. C. Harper-Wynne M. Dowsett G. Ross et al. Effects of the aromatase inhibitor letrozole on normal breast epithelial cell proliferation and metabolic indices in postmenopausal women: A pilot study for breast cancer prevention Cancer Epidem Biomarkers Prev 11 2002 614-621
15. M. Dowsett E. Folkerd Deficits in plasma oestradiol measurement in studies and management of breast cancer Breast Cancer Res 7 2005 1-4
16. M. Dowsett P.E. Goss T.J. Powles et al. Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: Optimization of therapeutic dose and route Cancer Res 47 1987 1957-1961